Vaiomer Overview

  • Founded

  • 2011

Founded
  • Status

  • Private

  • Employees

  • 11

Employees
  • Latest Deal Type

  • Grant

  • Latest Deal Amount

  • $546K

  • Investors

  • 3

Vaiomer General Information

Description

Developer of microbiome biotechnology designed to offer biomarker identification services. The company contributes to the discovery of innovative tools, biomarkers, and therapeutic targets related to tissue microbiome that helps to establish early prognosis and therapies for numerous diseases such as cardiometabolic diseases, obesity, diabetes, liver fibrosis, cirrhosis, cardiac failure, neurodegenerative disorders, and infectious diseases, enabling doctors to identify bacterial community profiles.

Contact Information

Website
www.vaiomer.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
  • 516 Rue Pierre et Marie Curie
  • 31670 Labege
  • France
+33 05 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vaiomer Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 04-Apr-2019 $546K 000.00 Completed Generating Revenue
2. Accelerator/Incubator 20-Feb-2013 000.00 000.00 Completed Generating Revenue
1. Accelerator/Incubator 15-Feb-2013 Completed Generating Revenue
To view Vaiomer’s complete valuation and funding history, request access »

Vaiomer Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of microbiome biotechnology designed to offer biomarker identification services. The company contributes to th
Biotechnology
Labege, France
11 As of 2023
000.00
0000000000 000.00

000000

incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nost
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000

000000

ercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute ir
0000 000000000
Cambridge, MA
000 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vaiomer Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Formerly PE-Backed Cambridge, MA 000 00000 000000000 00000
0000000 0000000000 Venture Capital-Backed Cambridge, MA 000 00000 00000000000 00000
00000000 Venture Capital-Backed Cambridge, MA 000.00 0000000000 0 000.00
0000 00000000000 Venture Capital-Backed Somerville, MA 0 000.00 0000000000 0 000.00
00000000 Venture Capital-Backed Paris, France 00 00000 0000000000 0 00000
You’re viewing 5 of 27 competitors. Get the full list »

Vaiomer Patents

  • 4

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Vaiomer Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10213434-B2 Use of factor xa inhibitors for regulating glycemia Active 08-Apr-2015 00000000000
EP-3078378-B1 Use of factor xa inhibitors for regulating glycemia Active 08-Apr-2015 00000000000
EP-3078378-A1 Use of factor xa inhibitors for regulating glycemia Active 08-Apr-2015 00000000000 00
US-20180161334-A1 Use of factor xa inhibitors for regulating glycemia Active 08-Apr-2015 A61K31/5377

Vaiomer Executive Team (6)

Name Title Board Seat Contact Info
Michael Courtney Co-Founder & Co-Chief Executive Officer
Jerome Fourtanier Co-Chief Executive Officer
Rémy Burcelin Co-Founder & President of the scientific advisory board
Benjamin Lelouvier Ph.D Chief Scientific Officer & Scientific Director
Jacques Amar Co-Founder
You’re viewing 5 of 6 executive team members. Get the full list »

Vaiomer Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vaiomer Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 SME Instrument Government 000 0000 000000 0
Nubbo Accelerator/Incubator Minority 000 0000 000000 0
Prologue Biotech Accelerator/Incubator Minority 000 0000 000000 0
To view Vaiomer’s complete investors history, request access »

Ready to get started?

Request a free trial